Viridian Therapeutics, Inc. (VRDN)
17.26
+0.26
(+1.53%)
USD |
NASDAQ |
May 27, 16:00
17.26
0.00 (0.00%)
After-Hours: 19:37
Viridian Therapeutics Cash from Investing (Quarterly) : 77.26M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -716.00M |
| Plus Therapeutics, Inc. | -8.533M |
| Perspective Therapeutics, Inc. | -109.55M |
| AVITA Medical, Inc. | 2.041M |
| Twist Bioscience Corp. | -12.71M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -119.65M |
| Cash from Financing (Quarterly) | 6.357M |
| Free Cash Flow | -304.30M |
| Free Cash Flow Per Share (Quarterly) | -1.171 |
| Free Cash Flow to Equity (Quarterly) | -120.16M |
| Free Cash Flow to Firm (Quarterly) | -116.22M |
| Free Cash Flow Yield | -19.59% |